跳至主要内容
临床试验/CTRI/2024/07/071736
CTRI/2024/07/071736尚未招募不适用

Acute toxicities and dosimetry associated with conventional and hypo fractionated adjuvant radiation in carcinoma breast.

Dr.Harikrishna Suresh1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月12日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To evaluate the acute reactions IN both conventional and hypo fractionated regimens.

研究概览

简要总结

The  study aims to evaluate the acute reactions and dosimetry in conventional  fractionationated radiotherapy compared to hypofractionated radiotherapy in  breast cancer patients. It also aims to assess the doses to  the organs at risk. The research question or hypothesis is that hypo - fraction  radiotherapy is comparable to convntional fractionation  radiotherapy in terms of acute adverse effects and dosimetric parameters.Aditionally hypo-fractionated radiotherapyis expected to improve patient compliance.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who are above the age of 18 years diagnosed with early stage or locally advanced carcinoma breast, has undergone mastectomy or breast conservative surgery who will be required to undergo adjuvant radiotherapy.

排除标准

  • PATIENTS WITH METASTATIC DISEASE PATIENTS WITH RELAPSE MENTALLY CHALLENGED PATIENTS.

结局指标

主要结局

To evaluate the acute reactions IN both conventional and hypo fractionated regimens.

时间窗: BEFORE THE STARTING OF THE TREATMENT 0 WEEK | DURING THE TREATMENT 4 TH WEEK | POST TREATMENT 2 MONTH 6 MONTHS

次要结局

  • To assess the quality of life(At the end of the treatment)

研究者

发起方
Dr.Harikrishna Suresh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

YENEPOYA UNIVERSITY MEDICAL COLLEGE HOSPITAL

DEEMED TO BE UNIVERSITY NABH ACCREDITATED

研究点 (1)

Loading locations...

相似试验